Profile of Invasive Fungal Diseases (IFD) among Severely Critically Ill non-neutropenic patients in the HCU or ICU at a Single Referral Hospital in Indonesia
Authors:
- Siti PratiekauriSPSiti Pratiekauri
- Nina MarianaNMNina Mariana
- Aninda Dinar WidiantariAWAninda Dinar Widiantari
- Maria Lawrensia TampubolonMTMaria Lawrensia Tampubolon
- Surya Oto WijayaSWSurya Oto Wijaya
- Rosamarlina RosamarlinaRRRosamarlina Rosamarlina
- Dian Wahyu TanjungDTDian Wahyu Tanjung
- Farida MurtianiFMFarida Murtiani
Open Access
- 30 September 2026
- journal article
- Published by Oriental Scientific Publishing Company in Biomedical and Pharmacology Journal
- Vol. 3 (19) , 2710-2716
Abstract
Invasive fungal diseases (IFD) are responsible for more than 1.5 million deaths globally annually. Candida spp. and Aspergillus spp. are the most frequent causes of healthcare-associated fungal infections, particularly in critically ill patients. This study aimed to describe severely critically ill patients with IFD caused by Candida spp. and Aspergillus spp. A cross-sectional study was conducted from July to December 2021 in the High Care Unit (HCU) and Intensive Care Unit (ICU) of Sulianti Saroso Hospital. We enrolled non-neutropenic patients with pneumonia or sepsis. Blood, lung exudate, and urine samples were collected from each patient for fungal testing. We performed mycological examination by culture and serology (galactomannan test used to detect Aspergillus antigen). Proven, probable, and possible are proposed as levels of IFD probability. Descriptive statistics were used to summarize the variables. Among 67 severely crititcally ill patients in the HCU and ICU who met the criteria. Blood samples were collected from 48 males and 19 females and then investigated. Most patients experienced pneumonia (87.0%), respiratory failure (76.1%), and sepsis (56.7%). Candida albicans was most commonly found in sputum (28.4%) and urine (25.4%), while Aspergillus fumigatus was found in sputum (3.0%). Candida parapsilosis and Candida duobushaeminlonii were found in the blood (4.5% and 1.5%, respectively), which is causing probable and possible IFDs. This study showed that invasive fungal disease was identified in non-neutropenic patients with severe to critical cases at HCU/ICU. The main cause of IFD is Candida albicans, while a small number of cases are caused by Aspergillus fumigatus, Aspergillus flavus, and Aspergillus niger. The fungi are commonly found in sputum and urine, whereas Candida duobushaemulonii and Candida parapsilosis were detected in blood cultures.Keywords
This publication has 20 references indexed in Scilit:
- Monitoring the Diversity and Antifungal Susceptibility of Candida Isolates at Adam Malik Hospital, Medan, IndonesiaInternational Journal of Microbiology, 2026
- Beyond guidelines: what do I need to know when dealing with fungal diagnostics?Clinical Microbiology and Infection, 2025
- Treatment of Invasive Pulmonary Aspergillosis and Preventive and Empirical Therapy for Invasive Candidiasis in Adult Pulmonary and Critical Care Patients: An Official American Thoracic Society Clinical Practice GuidelineAmerican Journal of Respiratory and Critical Care Medicine, 2025
- Clinical Characteristics, Risk Factors and Outcomes of Invasive Fungal Disease in Critically III Patients with Hematological Malignancy: A Retrospective StudyClinical Lymphoma Myeloma and Leukemia, 2024
- Performance of the galactomannan test for the diagnosis of invasive pulmonary aspergillosis using non-invasive proximal airway samplesJournal of Infection, 2024
- Global incidence and mortality of severe fungal diseaseThe Lancet Infectious Diseases, 2024
- Prevalence and Healthcare Burden of Fungal Infections in the United States, 2018Open Forum Infectious Diseases, 2022
- EORTC/MSGERC Definitions of Invasive Fungal Diseases: Summary of Activities of the Intensive Care Unit Working GroupClinical Infectious Diseases, 2021
- Epidemiology and Mortality-Associated Factors of Invasive Fungal Disease in Elderly Patients: A 20-Year Retrospective Study from Southern ChinaInfection and Drug Resistance, 2020
- Drug–laboratory interaction between beta-lactam antibiotics and the galactomannan antigen test used to detect mould infectionsThe Brazilian Journal of Infectious Diseases, 2014